Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics.

"Declaration of competing interest The authors declare that there are no conflicts of interest."

"This work was financially supported by the National Science and Technology Major Project of China (Grant No.: 2018ZX09711001), 10.13039/501100005090Beijing Nova Program (Grant No.: Z211100002121127), Beijing Natural Science Foundation (Grant No.: L212059), Fundamental Research Funds for the Central Universities (Grant No.: 3332021101), and CAMS Innovation Fund for Medical Sciences (CIFMS, Grant No.: 2022-I2M-JB-011). Jun Ye and Lin Li: Conceptualization, Methodology, Investigation, Formal analysis, Writing - Original draft preparation; Jiye Yin, Hongliang Wang, Renjie Li, and Yanfang Yang: Methodology, Investigation; Yongbiao Guan and Xuejun Xia: Supervision, Project administration; Yuling Liu: Supervision, Project administration, Funding acquisition, Writing - Reviewing and Editing."